Nuri Gueven

5.1k total citations · 1 hit paper
97 papers, 4.0k citations indexed

About

Nuri Gueven is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nuri Gueven has authored 97 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Nuri Gueven's work include DNA Repair Mechanisms (26 papers), Cancer-related Molecular Pathways (19 papers) and Mitochondrial Function and Pathology (13 papers). Nuri Gueven is often cited by papers focused on DNA Repair Mechanisms (26 papers), Cancer-related Molecular Pathways (19 papers) and Mitochondrial Function and Pathology (13 papers). Nuri Gueven collaborates with scholars based in Australia, Germany and United States. Nuri Gueven's co-authors include Martin F. Lavin, Philip Chen, Rajaraman Eri, Sergei Kozlov, Steven E. Bottle, Emma Rybalka, Geoffrey W. Birrell, Michael A. Erb, Glenn A. Jacobson and Shaun P. Scott and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Nuri Gueven

96 papers receiving 3.9k citations

Hit Papers

The complexity of p53 stabilization and activation 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuri Gueven Australia 34 2.9k 820 537 382 329 97 4.0k
Amy‐Joan L. Ham United States 38 3.2k 1.1× 616 0.8× 722 1.3× 272 0.7× 380 1.2× 69 5.1k
Carola Y. Förster Germany 33 1.6k 0.5× 673 0.8× 358 0.7× 295 0.8× 410 1.2× 110 4.4k
Phuong Le United States 34 2.1k 0.7× 614 0.7× 314 0.6× 692 1.8× 458 1.4× 75 4.0k
Xiaodong Cheng United States 37 3.4k 1.2× 534 0.7× 288 0.5× 626 1.6× 485 1.5× 102 5.0k
Patric Turowski United Kingdom 29 2.2k 0.8× 565 0.7× 254 0.5× 299 0.8× 376 1.1× 44 3.9k
Hong Zhao United States 36 2.1k 0.7× 453 0.6× 335 0.6× 183 0.5× 229 0.7× 84 2.9k
Xin Liu China 33 2.1k 0.7× 427 0.5× 519 1.0× 202 0.5× 429 1.3× 178 3.9k
Guido Lenz Brazil 38 2.1k 0.7× 640 0.8× 553 1.0× 373 1.0× 259 0.8× 134 4.3k
Henry J. Lin United States 31 2.7k 1.0× 423 0.5× 556 1.0× 551 1.4× 208 0.6× 90 4.2k
Lei Wei United States 41 4.3k 1.5× 834 1.0× 535 1.0× 323 0.8× 498 1.5× 103 6.4k

Countries citing papers authored by Nuri Gueven

Since Specialization
Citations

This map shows the geographic impact of Nuri Gueven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuri Gueven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuri Gueven more than expected).

Fields of papers citing papers by Nuri Gueven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuri Gueven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuri Gueven. The network helps show where Nuri Gueven may publish in the future.

Co-authorship network of co-authors of Nuri Gueven

This figure shows the co-authorship network connecting the top 25 collaborators of Nuri Gueven. A scholar is included among the top collaborators of Nuri Gueven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuri Gueven. Nuri Gueven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Paul, Alok Kumar, Mohammed Rahmatullah, Polrat Wilairatana, et al.. (2022). Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour. Pharmaceuticals. 15(7). 789–789. 1 indexed citations
3.
Ashton, Trent D., et al.. (2021). Direct Amidation to Access 3-Amido-1,8-Naphthalimides Including Fluorescent Scriptaid Analogues as HDAC Inhibitors. Cells. 10(6). 1505–1505. 7 indexed citations
4.
Premilovac, Dino, Lisa Foa, Qianyi Zhang, et al.. (2021). Novel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy. International Journal of Molecular Sciences. 22(3). 1016–1016. 9 indexed citations
5.
Smith, Jason A., et al.. (2021). Bioactivity Profiles of Cytoprotective Short-Chain Quinones. Molecules. 26(5). 1382–1382. 2 indexed citations
6.
Paul, Alok Kumar, Craig M. Smith, Mohammed Rahmatullah, et al.. (2021). Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals. 14(11). 1091–1091. 140 indexed citations
7.
Paul, Alok Kumar, Nuri Gueven, & Nikolas Dietis. (2021). Profiling the Effects of Repetitive Morphine Administration on Motor Behavior in Rats. Molecules. 26(14). 4355–4355. 17 indexed citations
8.
Timpani, Cara A., Craig A. Goodman, Christos G. Stathis, et al.. (2020). Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. Scientific Reports. 10(1). 1125–1125. 27 indexed citations
9.
Gueven, Nuri, et al.. (2020). Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma. Pharmaceuticals. 13(11). 368–368. 5 indexed citations
10.
Azimi, Iman, et al.. (2020). Comparative In Vitro Toxicology of Novel Cytoprotective Short-Chain Naphthoquinones. Pharmaceuticals. 13(8). 184–184. 3 indexed citations
11.
Gueven, Nuri, et al.. (2020). Idebenone: When an antioxidant is not an antioxidant. Redox Biology. 38. 101812–101812. 70 indexed citations
12.
Bell, Toby D. M., et al.. (2020). Mixed alkoxy/hydroxy 1,8-naphthalimides: expanded fluorescence colour palette and in vitro bioactivity. Chemical Communications. 56(50). 6866–6869. 15 indexed citations
13.
Timpani, Cara A., et al.. (2020). Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?. Pharmaceuticals. 13(10). 306–306. 63 indexed citations
14.
Gueven, Nuri, Kevin J. Spring, Kdk Ahuja, et al.. (2020). Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study. Marine Drugs. 18(3). 143–143. 19 indexed citations
15.
16.
McCartney, Paul J., et al.. (2019). Amide linked redox-active naphthoquinones for the treatment of mitochondrial dysfunction. MedChemComm. 10(3). 399–412. 13 indexed citations
17.
Lean, Qi Ying, et al.. (2016). Non-Anticoagulant Oligosaccharides of Enoxaparin Relieve Chemical-Induced Acute Colitis. eCite Digital Repository (University of Tasmania). 1 indexed citations
18.
Lean, Qi Ying, Rajaraman Eri, J. Helen Fitton, Rahul P. Patel, & Nuri Gueven. (2015). Fucoidan Extracts Ameliorate Acute Colitis. PLoS ONE. 10(6). e0128453–e0128453. 108 indexed citations
19.
Brown, James A. L., Tara L. Roberts, Renée S. Richards, et al.. (2011). A Novel Role for hSMG-1 in Stress Granule Formation. Molecular and Cellular Biology. 31(22). 4417–4429. 39 indexed citations
20.
Gatei, Magtouf, Burkhard Jakob, Philip Chen, et al.. (2011). ATM Protein-dependent Phosphorylation of Rad50 Protein Regulates DNA Repair and Cell Cycle Control. Journal of Biological Chemistry. 286(36). 31542–31556. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026